Emergency contraceptive (EC) pills: Key market research findings
- The Americas dominate the market geographically
- Increased awareness propels market growth
- Key vendors – Allergan, Lupin, Mankind, Piramal, and Teva
Technavio’s market research analysts predict the global market for emergency contraceptive pills to grow at a CAGR of almost 2% between 2016 and 2020. The increase in unplanned pregnancies across the globe is one of the fundamental factors fueling the growth of this market. Unprotected sexual intercourse, incorrect use of contraceptives, contraceptive failure, forgotten pills, or cases of sexual assault can lead to unplanned pregnancies. Use of effective EC pills can prevent 90% of abortion-related complications and 20% of pregnancy-related morbidity and mortality cases in developing countries. During 2015, the Americas accounted for about 40% of the overall market share to become the dominant shareholder in the global EC pills market. The demand from the teenager segment, with teenage pregnancy being a major issue in developed countries like the US will fuel the growth of the EC pill market in the Americas during the forecast period.
The new industry research report from Technavio discusses in detail the key drivers and trends responsible for the growth of this market and its sub-segments.
“There is increased awareness about EC pills among consumers owing to social marketing initiatives by vendors and organizations. A growing number of social network users worldwide are motivating marketers to invest in social media marketing to increase sales and maximize profits. Such programs offer creative, effective, and successful ideas about reproductive health products and services globally, particularly in developing countries. Educated young adults use social networking in their day-to-day lives,” says Abhay Sinha, Lead Analyst, New Coverage, Technavio Research.
Legal support by governments across countries plays a vital role in the growth of this market. A lot of EC pills are available to all ages. These pills can also be accessed from pharmacies, clinics, hospitals, and other channels without any prescription. Women under the age of 17 require a prescription for some EC pills in most of the distribution channels across the US. Similarly, in other countries such as the UK, Spain, France, India, and China, legal developments are changing the purchase criteria for EC pills.
The key vendors in the market include Allergan, Lupin, Mankind, Piramal, and Teva. The global EC pills market is highly fragmented with the presence of a large number of branded and generic brand providers. Vendors in the market face stiff competition from direct and indirect competitors on the basis of effectiveness, price, and promotions. The availability of generic products at a low price by regional vendors is eating up the shares of market vendors dealing in original brands; thereby, hampering the growth and development of branded pills.
A more detailed analysis is available in the Technavio report, Global EC Pills Market 2016-2020.
We can customize reports by other regions and specific segments upon request.
Other related reports:
